Article

Empathy dysfunction in children and adolescents with disruptive behavior disorders

Research Centre Adolescent Development, Utrecht University, 3508 TC Utrecht, The Netherlands.
European journal of pharmacology (Impact Factor: 2.68). 10/2009; 626(1):97-103. DOI: 10.1016/j.ejphar.2009.10.016
Source: PubMed

ABSTRACT In this essay, we focus on empathy in children and adolescents with disruptive behavior disorders (DBD), based on the assumption that lack of empathy is a risk factor for the development of DBD. We reflect on the heterogeneity of DBD, the complex nature of the empathy construct, discuss empathy's role in aggression, and review recent findings from studies on empathic skills in children and adolescents with DBD. Research suggests that the mechanisms underlying empathy problems may be different for DBD subtypes. Individuals with psychopathic tendencies may show a selective impairment in empathy with sadness and fear due to abnormalities in neural circuits connected with the amygdala. Individuals without these tendencies may show little empathy for a variety of reasons, such as hostile attributions, anxiety and/or poor regulatory skills. Understanding more about the nature and causes of empathy dysfunction in DBD could aid in identifying subtypes and help to improve prevention and intervention programs. Suggestions for future research are made.

Download full-text

Full-text

Available from: Anton van Boxtel, Jul 02, 2015
1 Follower
 · 
373 Views
  • Source
    Interaction Studies 01/2015; · 1.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The hippocampus is a critical brain region for human memory function, particularly the encoding of new episodic memories. Recent experiments based on rats running for a food reward show that temporal sequences of place cell firings are encoded in the hippocampus during waking exploration, and replayed at a twenty-fold increased rate during slow wave sleep. We show that a suitable hippocampal model using spiking neurons, and recent results from synaptic plasticity research, can replicate these results, and provide answers to important questions about the function of sleep and the mechanisms of neural plasticity. We also suggest avenues of further research, and make predictions for experimental verification.
    Neural Networks, 2004. Proceedings. 2004 IEEE International Joint Conference on; 08/2004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Conduct disorders are the most frequent psychiatric diagnosis in the pediatric and adolescent population, with different etiology and difficult to treat. Delinquent, aggressive, and impulsive behavior, lack of empathy and inability to predict possible consequences of the behavior lead to significant desadaptation and danger for these patients. In clinical practice, focus is usually given on social and psychological causes of conduct disorders ignoring possible biological factors in etiology and pathophysiology. A clinical case described in this article shows the linkage between frontal brain dysfunction and behavioral symptoms. The first clues of organic brain disorder were multiple and severe symptoms of disinhibition resistant to treatment with dopaminergic drugs and the results of neuropsychological testing. Computed tomography, magnetic resonance imagining, and single-photon emission computed tomography findings were minor and not supported by associated neurological symptoms. However, the location of alterations of brain structure and perfusion significantly correlated with psychopathology. Clarification of the organic cause of the conduct disorder allowed choosing an effective strategy of psychopharmacologic treatment. A positive clinical effect was achieved after switching the treatment from dopaminergic antipsychotic drugs to carbamazepine, which modulates the GABAergic system. Presenting this clinical case, we intended to emphasize the importance of careful attention to the findings of neurovisual and neuropsychological testing diagnosing conduct disorders and individually choosing the most effective psychopharmacologic treatment.
    Medicina (Kaunas, Lithuania) 01/2010; 46(12):827-34. · 0.51 Impact Factor